ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: One-year results

Transplantation Proceedings

Volumn 35, Issue 6, 2003, Pages 2100-2101

  Tullius, S G ^a   Pratschke, J ^a   Strobelt, V ^a   Kahl, A ^a   Reinke, P ^a   May, G ^a   Frei, U ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART DISEASE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0141838841     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00679-1     Document Type: Conference Paper

References (6)

1. Kahan B.D., Rajagopalan P.R., Hall M., et al. Transplantation. 67:1999;276.
2. Nashan B., Moore R., Amlot P., et al. Lancet. 350:1997;1193.
3. Sollinger H., Kaplan B., Pecovitz M.D., et al. Transplantation. 72:2001;1915.
4. Sollinger H.W. Transplantation. 60:1995;225.
5. Mayer A.D., Dmitrewski J., Squiffelt J.P., et al. Transplantation. 64:1997;436.
6. Garcia I. Transplant Proc. 34:2002;1638.